adding glp-1 to insulin Traveling with a GLP-1? You Might Be Packing it Wrong, Say a Doctor and a Pharmacist Toujeo® U-300 (insulin glargine) injection

At Flow Wellness, our providers review medication instructions with patients and are available to answer dosing questions throughout treatment

Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance

To maximize results: Small daily habits can have a major impact on your overall results

Diabetes Care 2022;45:217881

Key mechanistic features: Pulsatile GH release: Maintains natural GH secretion patterns rather than constant elevation Feedback preservation: Does not override normal hypothalamic-pituitary feedback loops IGF-1 elevation: Secondary increase in insulin-like growth factor-1 (IGF-1) through hepatic stimulation Lipolytic effects: Documented reduction in visceral adipose tissue (VAT) in clinical trials Tesamorelin FDA Approval History The Egrifta FDA approval timeline represents one of the few success stories for peptide therapeutics reaching market authorization